Your comparisons are meaningless, as FY14 is history and almost a different company. MCP has divested under-performing businesses and stock lines, moving to higher quality growth items such as new lines in health and beauty products, hence reducing revenue. Underlying earnings per share is up around 10% and EBIT is up around 14% on much lower revenues. That is a quality result which should continue in FY17.
- Forums
- ASX - By Stock
- Ann: FY2016 Results Release Presentation-MCP.AX
MCP
mcpherson's limited
Add to My Watchlist
0.00%
!
23.0¢

Your comparisons are meaningless, as FY14 is history and almost...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.10M |
Open | High | Low | Value | Volume |
23.0¢ | 23.5¢ | 23.0¢ | $24.72K | 107.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 6329 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22 | 0.230 |
2 | 30444 | 0.225 |
3 | 26000 | 0.220 |
1 | 4760 | 0.210 |
5 | 50460 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 6329 | 1 |
0.240 | 121094 | 5 |
0.245 | 10000 | 1 |
0.250 | 16900 | 2 |
0.270 | 24085 | 3 |
Last trade - 14.34pm 18/06/2025 (20 minute delay) ? |
Featured News
MCP (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online